Search

502 Result(s)
Sort by

Transforming pig farming through AI

Transforming pig farming through AI

With our livestock farming technology based on sound analytics, we are improving pig farm practices, producing healthier pigs and a better farm economy.
It Takes 2

It Takes 2

It Takes 2 people – a patient and a HCP, and 2 tests – a blood and a urine test–to help detect CKD. Early testing can drive earlier diagnosis and treatment.
Daniel Kiesenhofer

Daniel Kiesenhofer

Diverse, caring, collaborative - Daniel Kiesenhofer on Boehringer Ingelheim
Dirk Esser

Dirk Esser

Diverse, caring, collaborative - Dirk Esser on Boehringer Ingelheim
Retinal Health Research

Retinal Health Research

Our research is targeting key mechanisms in the pathogenesis of retinal diseases – vascular dysfunction, neuronal dysfunction and neuronal inflammation.
Living With Cancer

Living With Cancer

Every cancer journey is unique. Listen to the first-hand experiences of people living with cancer.
Partnering in Retinal Health

Partnering in Retinal Health

Our partnering interests in retinal diseases offer opportunities for collaboration to complement our pipeline and advance treatment and delivery.
Ann-Kathrin Koller

Ann-Kathrin Koller

Diverse, caring, collaborative - Ann-Kathrin Koller on Boehringer Ingelheim
Fight against COVID-19 pandemic

Fight against COVID-19 pandemic

Press release on Boehringer Ingelheim's half-year figures 2020. Business development from January to June 2020.
Chronic kidney disease is a silent killer

Chronic kidney disease is a silent killer

Living with chronic kidney disease can have drastic impacts on a patient and their family’s life. A patient and her caregiver share their story on managing it.
Life stages of cats

Life stages of cats

Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.
Stroke symptoms

Stroke symptoms

The Angels initiative, stroke symptoms, giving life a chance, optimizing stroke care
Fast-Track-Designation-NASH

Fast-Track-Designation-NASH

Boehringer Ingelheim and Zealand Pharma announced that the FDA granted Fast Track Designation to the dual agonist BI 456906 for adults with NASH.